Phathom Pharmaceuticals, Inc. PHAT Accrued interest
Accrued interest at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestPayableCurrent.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s accrued interest.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s accrued interest?
- Phathom Pharmaceuticals, Inc. (PHAT) reported accrued interest of $1.68M in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s accrued interest changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s accrued interest decreased by 7.0% year-over-year, from $1.8M to $1.68M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s accrued interest?
- Over 5 years (2020 to 2025), Phathom Pharmaceuticals, Inc.'s accrued interest has grown at a 42.5% compound annual growth rate (CAGR), from $312K to $1.83M.
- What does accrued interest mean?
- Interest expense accrued but not yet paid on outstanding debt obligations, based on contractual interest rates and time elapsed.